TAGline Spring 2018: Bend the curves

Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible. But in the context of public health strategies with ambitious targets and formidable stakeholder engagement, it is an undeniable facet of progress. In this issue of TAGline, Treatment Action Group (TAG) highlights some important recent successes and challenges in meeting its overarching goals: moving beyond achingly slow trends and sharply bending the curves on new HIV, hepatitis C, and TB infections, suffering, and deaths.

Spring TAGline contains:

• Bend the Curves:
  Activism and the Elimination of HIV, HCV, and TB
  By Tim Horn

• The Usual Suspects:
  Common Challenges for ETE Planning and Implementation in Emerging Jurisdictions
  By Jeremiah Johnson

• New York State EtE Campaign Update:
  Successes & Challenges
  By Jeremiah Johnson

• The Role of Vaccines and Cures in HIV Elimination
  By RIchard Jefferys

• It’s up to You, New York:
  Moving towards HCV Elimination in the Empire State
  By Annette Gaudino

• Global HCV Elimination Targets and Challenges:
  An Interview with Andrew Hill
  By Bryn Gay & Annette Gaudino

• From Moscow to New York and Beyond:
  The Future of Tuberculosis Research and Development
  By Safiqa Khimani and Mark Harrington

• The United Nations’ Back Yard:
  TB Elimination in New York State and the U.S.
  By Erica Lessem

• In a State of Disunion:
  HIV, TB, and HCV Elimination Policies and Priorities Under the Trump Administration
  By Suraj Madoori

TAGline Spring 2018

Source: Treatment Action Group